Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Cashflows

v3.22.1
Consolidated Statement of Cashflows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities    
Net income (loss) $ (33,172) $ (2,499)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities    
Depreciation, amortization and accretion expense 12,490 49
Amortization of debt issuance costs 699 0
Amortization of intangibles and below-market contracts (1,103) 0
Return on investment in equity method investments 3,912 0
Equity in earnings of equity method investments (1,429) 0
Total (gains) losses on derivatives, net 19,915 0
Net cash received (paid) in settlement of derivatives (229)  
Net cash received (paid) in settlement of derivatives   0
Forgiveness of Paycheck Protection Loan 0 (200)
Stock-based compensation expense 5,753 32
Changes in operating assets and liabilities:    
Accounts receivable (768) (8)
Inventory (1,401) 0
Prepaid expenses and other current assets (678) (432)
Accounts payable - trade 8,612 951
Accrued and other liabilities 5,634 (288)
Other non-current assets 246 0
Other long-term liabilities (12) 37
Net cash provided by (used in) operating activities 18,469 (2,358)
Cash flows from investing activities    
Acquisition of Aria, net of cash acquired 1,876 0
Acquisition of assets and businesses (7,013) 0
Additions to property, plant and equipment and progress payments (61,446) (32,346)
Contributions to equity method investments (4,024) 0
Return of investment in equity method investments 4,088 0
Net cash used in investing activities (66,519) (32,346)
Cash flows from financing activities    
Borrowings on line of credit agreement 0 1,512
Proceeds from long-term debt, net of issuance costs (113) 56,496
Repayments of long-term debt (2,794) (3)
Payment of acquisition contingent consideration (1,650) 0
Capital contributions 0 70
Taxes paid on net share settled stock-based compensation awards (786) 0
Net cash provided by (used in) financing activities (5,343) 58,075
Net increase (decrease) in cash, cash equivalents and restricted cash (53,393) 23,371
Cash, cash equivalents and restricted cash - beginning of period 93,066 1,496
Cash, cash equivalents and restricted cash - end of period 39,673 24,867
Supplemental cash flow information    
Cash paid for interest 3,720 1,110
Non-cash investing activities    
Accruals of property, plant and equipment and biogas rights incurred but not paid $ 24,145 $ 4,800